 |
Articles: Pharmacoeconomics |
Prior Articles
Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention
Current Medical Research and Opinion, 10/01/09
Utilities of the EQ-5D: Transferable or Not
PharmacoEconomics, 09/30/09 Improving the Quantitative Basis of the Surgical Burden in Low-Income Countries
PLoS Medicine, 09/30/09
Free full text
Evaluation of cost effectiveness for conservative and active management strategies for acoustic neuroma
Clinical Otolaryngology, 09/30/09 A performance and theoretical cost analysis of endobronchial ultrasound-guided transbronchial needle aspiration in a UK tertiary respiratory centre
QJM: An International Journal of Medicine, 09/30/09 Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobacter jejuni and Campylobacter coli
Diagnostic Microbiology and Infectious Disease, 09/30/09 Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines
Current Medical Research and Opinion, 09/29/09 The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values
PharmacoEconomics, 09/28/09 Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors
Current Medical Research and Opinion, 09/24/09 Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
PharmacoEconomics, 09/23/09 The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia
PharmacoEconomics, 09/22/09 Head Lice Treatments and School Policies in the US in an Era of Emerging Resistance: A Cost-Effectiveness Analysis
PharmacoEconomics, 09/22/09 Six-Month Prophylaxis Is Cost Effective in Transplant Patients at High Risk for Cytomegalovirus Infection
Journal of the American Society of Nephrology, 09/21/09 A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US
PharmacoEconomics, 09/18/09 Methods for Measuring Temporary Health States for Cost-Utility Analyses
PharmacoEconomics, 09/18/09 Comparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations
PharmacoEconomics, 09/18/09 Determinants of Willingness to Pay for a New Therapy in a Sample of Menopausal-Aged Women
PharmacoEconomics, 09/14/09 Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation
Drugs & Aging, 09/14/09 The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US
PharmacoEconomics, 09/11/09 The need and total cost of Finnish eyecare services: a simulation model for 2005-2040
Acta Ophthalmologica, 09/11/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
152 Available Pages
|
|
